Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 5, Number 2—April 1999

Dispatch

Evaluating Diagnosis and Treatment of Oral and Esophageal Candidiasis in Ugandan AIDS Patients

Maurizio Ravera, Alberto Reggiori, Anna Maria Agliata, and Roberto Pidoto Rocco
Author affiliations: Regional Teaching Hospital, Hoima, Uganda

Main Article

Table

Characteristics of patients participat- ing in the study

No. Mean age
(yr) (S.D.) Sex
M/F
Oral candidiasis 85 24.0 (6.7) 32 / 53
Esophageal symptomsa 40 17 / 23
Nystatin group 20 23.9 (6.1) 7 / 13
Miconazole group 20 23.7 (6.6) 8 / 12
Esophageal candidiasis 77 23.7 (6.4) 27 / 50
Nystatin group 37 24.2 (6.5) 12 / 22
Miconazole group 40 23.4 (6.1) 15 / 28

aEsophageal symptoms are any of the following: odinophagia, dysphagia, retrosternal burning pain.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO